ir acelrx.com

AcelRx Pharmaceuticals, Inc Investors

Q2 2015 AcelRx Pharmaceuticals, Inc. Earnings Conference Call. 160;at430 pmET. Q2 2015 AcelRx Pharmaceuticals, Inc. Earnings Conference Call. Monday, August 3, 2015. 430 pmET. Click here for webcast. Click here to add this event to your calendar. ACRX Corporate Presentation - 5715. 160; 0.13. Data as of 080715 400 pm ET. Minimum 20 minute delay. AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results. Replication or redistribution of E.
traffic

OVERVIEW

This web page ir.acelrx.com presently has a traffic ranking of zero (the lower the better). We have explored one page inside the web page ir.acelrx.com and found twenty-seven websites referring to ir.acelrx.com.
Pages Crawled
1
Links to this site
27

IR.ACELRX.COM RANKINGS

This web page ir.acelrx.com is seeing varying levels of traffic for the whole of the year.
Traffic for ir.acelrx.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ir.acelrx.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ir.acelrx.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEB SITE

Welcome to AcelRx Pharmaceuticals, Inc

We are a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. For the treatment of cancer breakthrough pain; ARX-03.

WHAT DOES IR.ACELRX.COM LOOK LIKE?

Desktop Screenshot of ir.acelrx.com Mobile Screenshot of ir.acelrx.com Tablet Screenshot of ir.acelrx.com

IR.ACELRX.COM HOST

Our parsers caught that the main page on ir.acelrx.com took zero milliseconds to load. Our crawlers could not detect a SSL certificate, so therefore we consider this site not secure.
Load time
0 secs
SSL
NOT SECURE
Internet Protocol
104.91.183.85

PAGE TITLE

AcelRx Pharmaceuticals, Inc Investors

DESCRIPTION

Q2 2015 AcelRx Pharmaceuticals, Inc. Earnings Conference Call. 160;at430 pmET. Q2 2015 AcelRx Pharmaceuticals, Inc. Earnings Conference Call. Monday, August 3, 2015. 430 pmET. Click here for webcast. Click here to add this event to your calendar. ACRX Corporate Presentation - 5715. 160; 0.13. Data as of 080715 400 pm ET. Minimum 20 minute delay. AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results. Replication or redistribution of E.

CONTENT

This web page states the following, "Q2 2015 AcelRx Pharmaceuticals, Inc." We saw that the web page said " Q2 2015 AcelRx Pharmaceuticals, Inc." It also said " Monday, August 3, 2015. Click here to add this event to your calendar. ACRX Corporate Presentation - 5715. Data as of 080715 400 pm ET. AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results. Replication or redistribution of E."

SEEK SUBSEQUENT WEB PAGES

Investors Achillion Pharmaceuticals

Achillion to Present at the Barclays Global Healthcare Conference. Barclays Global Healthcare Conference 2018.

Acorda Therapeutics Inc - Investors

Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.

Investor Overview - Active Power Investors Relations

Our products are built on our elegant, field proven flywheel technology that delivers an unmatched combination of power density, reliability, and total cost of ownership. This combination enables our customers to achieve their availability, reliability, and budget goals. Q2 2015 Active Power, Inc. Active Power to Present at 43rd An.

Activision Blizzard, Inc. Investor Relations

is the largest and most profitable western interactive entertainment publishing company. It develops and publishes some of the most successful and beloved entertainment franchises in any medium, including. Call of Duty Online,. Activision Brings Strongest Ever Line-up to Gamescom 2015. Activision Blizzard Second Quarter Calendar 2015 Results Conference Call.